Whei Ying Lim
Pediatric Endocrinology · Mobile, ALNPI 1447668942
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.1% of the total across 205 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,721, more than ten times the $150 reported in 2020.
Across 205 payments — averaging $23.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$871
- Novo Nordisk$597
- Sanofi-aventis U.S. LLC$342
- Tolmar, Inc.$324
- BETA Bionics, Inc.$300
- Xeris Pharmaceuticals, Inc.$298
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,45994%
- Education$2806%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $871 |
| Novo Nordisk | 26 | $597 |
| Sanofi-aventis U.S. LLC | 7 | $342 |
| Tolmar, Inc. | 20 | $324 |
| BETA Bionics, Inc. | 9 | $300 |
| Xeris Pharmaceuticals, Inc. | 16 | $298 |
| Neurocrine Biosciences, Inc. | 9 | $226 |
| Dexcom, Inc. | 9 | $216 |
| Tandem Diabetes Care, Inc. | 6 | $164 |
| Pfizer | 9 | $154 |
| Ascendis Pharma Endocrinology Inc | 8 | $149 |
| Lilly USA, LLC | 7 | $146 |
| Insulet Corporation | 7 | $144 |
| Azurity Pharmaceuticals, Inc. | 6 | $134 |
| AstraZeneca | 4 | $95 |
| Arbor Pharmaceuticals, Inc. | 5 | $87 |
| Rhythm Pharmaceuticals, Inc. | 4 | $82 |
| Biomarin Pharmaceutical Inc. | 3 | $80 |
| Kyowa Kirin, Inc. | 3 | $77 |
| Tolmar Pharmaceuticals, Inc. | 4 | $68 |
| Alnylam Pharmaceuticals Inc. | 2 | $38 |
| Sequel Med Tech, LLC | 1 | $29 |
| Ultragenyx Pharmaceutical Inc. | 1 | $28 |
| Endo USA, Inc. | 1 | $22 |
| Medtronic | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $17 |
| Amryt Pharma Holdings Ltd | 1 | $17 |
| Sandoz | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TZIELD$224
- Lupron Depot$125
How this compares
$4,739 in reported general payments places this provider in the 80th percentile of 22 pediatric endocrinology providers in Alabama.
Other pediatric endocrinology in Mobile
- Anne Marie KaulfersMobile$19K
- Eliana Perez GarciaMobile$5K
- Kenneth RettigMobile$2K
- Samar BhowmickMobile$944
- Ambika AshrafBirmingham$39K
- Chelsea ZimmermanOpelika$29K
- Mary ScottBirmingham$9K
- Heather ChoatDothan$3K
- Kenneth McCormickBirmingham$2K
- Christy FosterBirmingham$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.